Millennium Management
PRVL

Millennium Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Millennium Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,400
Closed -$632K – 6866
2020
Q4 		$632K Buy
+27,400
New +$347K ﹤0.01% 4030

Millennium Management's PRVL Position: Q1 2021 in Review

Millennium Management sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 589,987 shares — an estimated $13.6M sold.

Millennium Management first reported a position in PRVL in Q2 2019 and held it in 6 quarters. The position peaked at $13.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • Millennium Management reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Millennium Management sold 589,987 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $13.6M.
  • Millennium Management first reported a position in Prevail Therapeutics Inc. Common Stock in Q2 2019 and held it in 6 quarters.
  • Millennium Management's Prevail Therapeutics Inc. Common Stock position peaked at $13.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Millennium Management's 13F filing for Q1 2021, filed 17 May 2021.